Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

March 4, 2022

Study Completion Date

April 1, 2022

Conditions
ColchicineDiabetes Mellitus, Type 2Coronary Artery DiseaseWhite Blood CellInflammationDiarrhea
Interventions
DRUG

Colchicine 0.5 mg

oral administration of Colchicine 0.5 mg once daily for 12 weeks

DRUG

Colchicine 0.25 mg

oral administration of Colchicine 0.25 mg once daily for 12 weeks

DRUG

Placebo

oral administration of Placebo once daily for 12 weeks

Trial Locations (5)

Unknown

Hiroshima University Hospital, Hiroshima

Kitasato University Hospital, Kanagawa

Urasoe Sogo Hospital, Okinawa

Dokkyo Medical University Nikko Medical Center, Tochigi

Showa University Hospital, Tokyo

All Listed Sponsors
lead

University of the Ryukyus

OTHER

NCT03376698 - Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease | Biotech Hunter | Biotech Hunter